Anbio Biotechnology (NNNN)

NASDAQ: NNNN · Real-Time Price · USD

11.59

+1.44 (14.19%)

At close: Jul 29, 2026, 4:00 PM EDT

11.99

+0.40 (3.45%)

Pre-market: Jul 30, 2026, 4:07 AM EDT

Anbio Biotechnology Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021
Revenue	8.65	8.65	8.19	6.71	4.43
Revenue Growth	24.95%	5.64%	21.95%	51.56%	-
Gross Profit	7.54	7.54	5.89	3.36	2.54
Operating Income	5.77	5.77	2	1.96	2.46
Net Income	6.4	6.4	2.37	2.25	2.54
Earnings Per Share	0.15	0.15	0.06	0.10	25358.00
EPS Growth	177.36%	162.50%	-46.67%	-100.00%	-

Revenue by Geography

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
European Union	5.15	5.15	5.62	4.66	20.3	4.09
Asia Pacific	1.52	1.52	0.51	0.07	3.19	-
North America	0.3	0.3	0.11	0.22	0.05	0.34
South America	0.27	0.27	1.48	1.65	-	-
Other Regions	1.41	1.41	0.47	0.11	-	-
Total	8.65	8.65	8.19	6.71	23.54	4.43

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Cash (Debt)	11.9	11.9	11.76	9.69	8.67	4.18
Net Cash Growth	-11.38%	1.19%	21.40%	11.75%	107.33%	-
Cash & Investments	11.9	11.9	11.76	9.69	8.67	4.18
Net Cash Per Share	0.27	0.27	0.28	0.45	86690.56	41813.25

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021
Operating Cash Flow	-6.74	-6.74	2.08	0.9	4.18
Free Cash Flow	-6.74	-6.74	2.08	0.9	4.18
Free Cash Flow Growth	-	-	131.57%	-78.52%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '21 Dec 31, 2021
Gross Margin	87.24%	87.24%	71.90%	50.07%	57.40%
Operating Margin	66.70%	66.70%	24.38%	29.22%	55.46%
Pretax Margin	74.06%	74.06%	28.99%	33.58%	57.26%
Profit Margin	74.06%	74.06%	28.99%	33.58%	57.26%
FCF Margin	-77.94%	-77.94%	25.42%	13.38%	94.42%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	79.04	204.56	-	-	-	-
PS Ratio	58.83	152.64	-	-	-	-